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Sonia Cordisco1,4, Riccardo Maurelli1,4, Sergio Bondanza1, Miria Stefanini2, Giovanna Zambruno3,
Liliana Guerra1 and Elena Dellambra1
Accumulation of senescent cells contributes to the reduced regenerative capacity in aged tissues. By evaluating
the molecular pathways of senescence in relation to proliferative potential of primary keratinocyte cultures
from young and old healthy donors, and from young patients with inherited defects leading to premature aging,
we demonstrated that p16INK4a is a reliable marker of both physiological and premature epidermal aging.
Analysis of the expression and activity of p16INK4a regulators showed that stem cell depletion, reduced
proliferation, and p16INK4a upregulation in keratinocytes derived from the chronologically and prematurely
aged epidermis strongly correlate with Bmi-1 downregulation. In highly proliferative tissues, replicative and
premature senescence participate in determining senescent cell accumulation. Our findings demonstrated that
Bmi-1 is downregulated in human keratinocytes during both in vitro processes, in parallel with p16INK4a
upregulation and accomplishment of clonal conversion. When premature senescence was induced by specific
exogenous stimuli, concomitant Ets-1 upregulation was also observed. Moreover, Bmi-1 inhibited Ets-1-
mediated p16INK4a upregulation. Finally, Bmi-1 overexpression reduced p16INK4a promoter activity and decreased
protein expression in aged and diseased keratinocytes, inducing a delay of clonal conversion and an increase of
cell clonogenic ability. Altogether these findings underline a key role of Bmi-1 downregulation in enforcing
aging in primary human keratinocytes.
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INTRODUCTION
Skin aging has two components: intrinsic and extrinsic aging.
Intrinsic (chronological) skin aging is due to progressive,
time-dependent changes in tissue. These modifications occur
as result of both the genetic program and the cumulative
insults from endogenous (overproduction of reactive oxygen
species (ROS) and mutation accumulation) and microenvir-
onmental (extracellular matrix modification as well as growth
factor and hormone dosage modulation) sources. In tissues
with high turnover, such as epidermis, there is an additional
component of aging for stem cells and their progeny, which
transiently amplify: replicative aging. Extrinsic aging (photoa-
ging) in the skin includes those changes, which are caused by
chronic Sun exposure, superimposed on chronological skin
aging (Yaar, 2006; Dro¨ge and Schipper, 2007).
Features of skin aging also manifest in children suffering
from specific genetic diseases, such as progeria, trichothio-
dystrophy (TTD), and xeroderma pigmentosum (XP). This
phenomenon is known as premature skin aging to distinguish
it from physiological aging (Navarro et al., 2006).
Epidermal tissue needs to be continuously renewed during
life and keratinocyte stem cells contribute to normal tissue
homeostasis and regeneration in response to injury or stress.
When a daughter stem cell is committed to differentiate, it
accomplishes several cycles of division, generating transient
amplifying (TA) cells that withdraw from the cell cycle to
execute the terminal differentiation program (Alonso and
Fuchs, 2003, and references herein). This transition from stem
to TA cells is named clonal evolution. However, there is a
decline in tissue regenerative potential with age that could be
ascribed to intrinsic aging of stem cells and/or to aging of the
tissue microenvironment where they reside (Rando, 2006).
Thus, accumulation of senescent cells during time is likely to
reduce the tissue regenerative capacity and to contribute to
the physiological aging of the tissue itself (Satyanarayana and
Rudolph, 2004; Kim and Sharpless, 2006).
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In vitro cellular senescence refers to both replicative and
premature senescence. In keratinocyte cultures, replicative
senescence is a gradual process, which occurs only when all
stem cells have completed their clonal evolution giving rise
to terminal TA cells, named paraclones. We and others have
previously reported that human keratinocyte replicative
senescence is associated with a progressive increase in the
expression of p16INK4a (Dellambra et al., 2000; Dickson
et al., 2000). In addition, we have recently demonstrated that
p16INK4a inactivation impairs clonal evolution in the
presence of p14ARF and p53 expression, identifying p16INK4a
as a major regulator of human keratinocyte replicative
senescence (Maurelli et al., 2006). Premature or accelerated
senescence can be induced by stress signals, such as
activation of oncogenes, strong mitogenic signals, ROS
accumulation, and direct DNA damage caused by genotoxic
agents. Increased p16INK4a and/or p19ARF (p14ARF in human
cells)/p53/p21Waf1 expression in some mammalian cells has
been correlated with this process. However, both types of
senescence display overlapping phenotypes and they could
both contribute to accumulation of senescent cells in tissues
during aging (Herbig and Sedivy, 2006).
Although the effectors of in vivo mammalian aging have
not been fully elucidated, senescence mediators, such as
p16INK4a, p19ARF /p14ARF, p53, and p21Waf1, have been
suggested to play a role in aging by limiting the long-term
growth of self-renewing cells (Satyanarayana and Rudolph,
2004; Kim and Sharpless, 2006). The Ink4a/Arf locus, which
encodes p16INK4a and p19ARF, has been reported as a robust
biomarker, and a possible effector, of rodent aging. An
increased expression of both proteins in vivo has been
demonstrated by immunohistochemical analysis in almost all
aged rodent tissues, and this expression can be attributed to
the expression of Ets-1, a p16INK4a transcriptional activator, as
well as to unknown Ink4a/Arf coregulatory molecules
(Krishnamurthy et al., 2004). In addition, alteration of p53
activity in mouse models induces premature aging, suggest-
ing the possible involvement of p53 in the regulation of the
mammalian aging (Tyner et al., 2002; Dumble et al., 2007).
More limited data are available for human aging. In aged
human skin, an increased expression of p16INK4a (Nielsen
et al., 1999) and downregulation of Bmi-1, a p16INK4a
repressor, have been detected at the immunohistochemical
level (Ressler et al., 2006).
The aim of this study was, therefore, to investigate the
involvement of cell senescence mediators in the mechanisms
of chronological and premature aging of human epidermis.
RESULTS
p16INK4a expression during human keratinocyte physiological
and premature aging
Primary keratinocytes from young and elderly donors at the
first passage of the in vitro culture were used as model
of in vitro physiological aging and analyzed for expression
of senescence mediators, proliferative potential, and para-
clone percentage. Paraclone number represents a direct
measurement of clonal evolution and progressive holoclone
depletion, which is indicative of stem cell depletion in vitro
(Barrandon and Green, 1987a; Mathor et al., 1996; Dellam-
bra et al., 2000).
The analysis of expression levels of products of the Ink4a/
Arf tumor-suppressor locus showed that p16INK4a expression
was detectable only in primary keratinocytes from subjects
older than 60 years (Figure 1a). Conversely, expression of
p63, a marker of keratinocytes endowed with high prolif-
erative capacity (Pellegrini et al., 2001), decreased with the
age of donors, suggesting stem cell depletion in elderly
subjects (Figure 1a). The expression of p14ARF, the second
product of the Ink4a/Arf locus that inhibits MDM2-mediated
degradation of p53 (Stott et al., 1998), was barely detectable
in keratinocytes independently of donor age. Expression of
p53 and its transcriptional target p21Waf1 did not significantly
vary in keratinocytes from young versus old donors
(Figure 1a). These findings were confirmed by the analysis
of a larger group of elderly individuals (Figure 1b). Among
epidermal differentiation markers, expression of involucrin
(Eckert et al., 1993) was higher in elderly donors (Figure 1b),
whereas 14-3-3s, a member of the 14-3-3 protein family
specifically expressed in suprabasal differentiating keratino-
cytes (Dellambra et al., 2000), did not significantly vary in
keratinocytes from young versus old donors (Figure 1b).
In parallel, the proliferative capacity of cultures from the
same donors was evaluated by serial subcultivation. As
previously reported (Rheinwald and Green, 1975), the
lifespan of cultured keratinocytes declines with increasing
age of donors. Indeed, cultures from elderly donors showed a
shorter lifespan than those from young controls (Figure 1c).
Furthermore, we observed a strong positive correlation
between paraclone percentage in keratinocytes analyzed
immediately after isolation from the skin biopsy (passage 0 in
Figure 1d) and p16INK4a expression levels in keratinocytes at
the first passage of the in vitro culture (Figure 1b). Of note,
among old individuals’ keratinocytes, those presenting the
lowest paraclone percentage (K111 and K115) showed the
lowest p16INK4a and the highest p63 expression levels
(compare Figure 1d and b). Absence of paraclones at passage
0 and concomitant undetectable levels of p16INK4a were
observed in all the young donors analyzed (K79 and P1
strains in Figure 1b and d, and paraclone data in Figure 2a for
individuals analyzed in Figure 1a, lanes 1–7). Thus, this
pattern represents a constant and typical feature of young
keratinocytes, as suggested by our previous studies (Dellam-
bra et al., 2000; Maurelli et al., 2006; Panacchia et al., 2009).
Conversely, keratinocyte strains from elderly donors, which
express high levels of p16INK4a already at first passage in
culture, are characterized by rapid increase in paraclones
during subcultivation (compare Figure 1d and b).
The same parameters were then investigated in young
patients affected by three genetic disorders characterized by a
premature skin aging phenotype, namely progeria, TTD, and
XP group-C (XP-C). Keratinocyte cultures from these patients
showed premature senescence as compared with healthy
donors of similar age (Figure 1e; see also Figure 1c).
Particularly, keratinocytes from two XP-C (XP-C1 and
XP-C2) and one TTD patient showed the shortest lifespan,
and cell senescence was accompanied by abrupt clonal
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Figure 1. Correlation between senescence marker expression and stem cell depletion in epidermal keratinocytes from aged donors and from young
patients with inborn defects leading to premature aging. (a, b) p16INK4a, p63, p14ARF, p53, p21Waf1, involucrin, and 14-3-3s expression was assessed by
western blotting using cell extracts prepared from first-passage keratinocyte cultures obtained from young versus elderly individuals. The corresponding strain
name and the donor age (years) are reported in each lane. HeLa (H) and A431 (A) cells were used as positive control for p14ARF and p53 expression, respectively.
GA3PDH served as a loading control. (c, d) Primary P1, K79, and P4 (black lines) human keratinocytes from young donors and primary K58 (violet line),
K111 (light blue line), K115 (orange line), Kp1 (red line), Kp2 (blue line), Kp3 (green line), Kp4 (pink line), and Kp5 (yellow line) human keratinocytes from
elderly donors were serially cultivated, and CFEs were performed at each cell passage. The number of cell doublings was calculated as described under
Materials and Methods. Panel c shows the cumulative number of cell generations per passage plotted against the total time in culture. Panel d shows the aborted-
colony values (% of paraclones) of keratinocytes expressed as the ratio between aborted colonies and the total number of colonies, plotted against
the cell passages. Passage 0 refers to clonal analysis performed immediately after keratinocyte isolation from the skin biopsy. (e, f) Primary human keratinocytes
from patients suffering from XP-C (XP-C1, orange line and XP-C2, light blue line), TTD (red line), and progeria (pink line), and from a representative donor
of similar age (black line) were serially cultivated, and CFEs were performed at each cell passage. The number of cell doublings was calculated as
described under Materials and Methods. Panel e shows the cumulative number of cell generations per passage plotted against the total time in culture.
Panel f shows the aborted-colony values (% of paraclones) of keratinocytes expressed as the ratio between aborted colonies and the total number of colonies,
plotted against the cell passages. Passage 0 refers to clonal analysis performed immediately after keratinocyte isolation from the skin biopsy. (g). p16INK4a, p63,
p14ARF, p53, and p21Waf1 expression was assessed by western blotting using cell extracts prepared from first-passage keratinocyte cultures obtained
from inguinal fold of patients suffering from XP-C (XP-C1 and XP-C2), TTD, and progeria, and normal young controls (NHK1, NHK2, and NHK3). The
corresponding strain name and the donor age (years) are reported in each lane. HeLa (H) and A431 (A) cells were used as positive control for p14ARF
and p53 expression, respectively. GA3PDH served as a loading control. (h) The optical density (OD) of the autoradiographic bands (western blot shown in
panel g) was quantified and normalized to GA3PDH for equal loading.
Figure 1 continued on the following page
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Figure 2. Bmi-1 expression in epidermal keratinocytes from young versus aged healthy donors and young patients with inborn defects leading to
premature aging. (a, b) Bmi-1 expression was assessed by western blotting using cell extracts prepared from first-passage keratinocyte cultures obtained
from young versus elderly donors. GA3PDH served as loading control. The corresponding donor age (years), CFE, and paraclone percentage of keratinocyte
cultures at passage 0, that is, at the moment of keratinocyte isolation and seeding from the skin biopsy, are reported in each lane. (c, d) The OD of the
autoradiographic bands (western blot shown in panels a and b) was quantified and normalized to GA3PDH for equal loading. Of note, in panel c, the
mean value (2.963) of the five young donors (2–20 years) was significantly lower (Po0.01) compared with the mean value (0.496) of the six adult and old
subjects (44–63 years). (e, f) Bmi-1, Ets-1, and Id-1 expression was assessed by western blotting using cell extracts prepared from first-passage keratinocyte
cultures obtained from young versus elderly donors (e) and from first passage keratinocyte cultures obtained from XP-C (XP-C1 and XP-C2), TTD, and
progeria, and a normal young control (NHK) (f). GA3PDH served as loading control.
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conversion (Figure 1e and f). The keratinocyte strain obtained
from a progeria patient showed an intermediate lifespan and pro-
gressive increase of paraclone percentage (Figure 1e and f).
Differently from young healthy donors, p16INK4a was
already expressed at the first in vitro passage in patient
keratinocytes (Figure 1g). p63 expression in XP-C1, XP-C2,
and TTD samples was lower than that in normal human
keratinocytes (NHKs) (Figure 1g). Indeed, densitometric
evaluation demonstrated a p63 decrease of 0.5-, 0.73-, and
0.47-fold, respectively, as compared with the average value
of the three NHK strains (Figure 1h). p14ARF levels were
below the level of detection (Figure 1g). Expression of p53
appeared slightly lower in XP-C2, TTD, and progeria
keratinocyte cultures as compared with that in young
controls, and p21Waf1 was slightly less expressed in all
patients’ keratinocyte cultures (Figure 1g). There was also a
strong positive correlation between paraclone percentage
(Figure 1f, passage 0) and p16INK4a expression in keratino-
cytes at the first in vitro passage (Figure 1g). Of note, the
progeria culture, that showed low levels of p16INK4a
expression, presented a low percentage of paraclones.
Altogether these findings demonstrate that, different from
p14ARF, p16INK4a is a marker of both human keratinocyte
physiological and premature aging. Importantly, p16INK4a
expression correlates with stem cell depletion in epidermal
tissue in both conditions.
Ets-1, Id-1, and Bmi-1 expression during human keratinocyte
physiological and premature aging
To investigate the factors responsible for the marked
accumulation of p16INK4a with aging, we determined the
expression of three key regulators of Ink4a/Arf locus
expression: (i) Bmi-1, a repressor of the Ink4a/Arf locus
(Dimri et al., 2002); (ii) Ets-1, an activator of p16INK4a; and
(iii) Id-1, a transcriptional repressor of p16INK4a (Ohtani et al.,
2001).
In primary keratinocytes at the first culture passage, Bmi-1
was much more expressed in young donors than in adult and
old subjects (Figure 2a, b, and e), as confirmed by
densitometric analyses (Figure 2c and d). The Bmi-1 amount
inversely correlated with paraclone percentage (Figure 2a
and b, and compare Figures 2e and 1d, passage 0). In
addition, the Bmi-1 decrease correlated with colony-forming
efficiency (CFE) reduction already in primary keratinocytes
from subjects older than 44 years (Figure 2a). Indeed, the
average CFE value of 13 young donors (2–21 years), most of
them showing high Bmi-1 expression, was 5.7%. In contrast,
the average CFE value of eight adult/old donors (44–74 years)
was 0.9% (Figure 2a and b).
To analyze Bmi-1 expression in vivo, immunohistochem-
istry was performed on skin biopsies obtained from seven
young (4–13 years) and eight elderly (70–85 years) donors. A
Bmi-1 nuclear staining was detected in basal keratinocytes
from young donor skin (Supplementary Figure S1a), whereas
a reduced number of Bmi-1-positive cells was found in skin
from elderly donors (Supplementary Figure S1b), in agree-
ment with the results obtained by western blotting on
cultured keratinocytes (Figure 2a, b and e).
Despite the inter-individual variability in Ets-1 and Id-1
levels, there was a trend toward inverse correlation between
Ets-1 and Id-1 amount (Figure 2e). Furthermore, there was no
correlation between paraclone percentage and Ets-1 or Id-1
expression (compare Figures 1d and 2e).
As photoaging induces cellular changes superimposed on
chronological skin aging effects, we also analyzed the same
parameters in keratinocyte cultures from photoexposed and
non-photoexposed skin areas of the same healthy old donor.
Although no significant difference in proliferative potential
was detected (data not shown), cultures obtained from
photoexposed areas of both donors presented increased
paraclone percentage (Supplementary Figure S2a, passage
0), higher levels of p16INK4a, and lower levels of Bmi-1
(Supplementary Figure S2b) than in the corresponding non-
photoexposed areas. On the other hand, no modulation of
Ets-1 and Id-1 expression could be detected (Supplementary
Figure S2b).
Downregulation of Bmi-1 was observed also in XP-C,
TTD, and progeria keratinocytes as compared with young
healthy control (Figure 2f, NHK). The levels of Ets-1 were
augmented in XP-C2, progeria, and TTD samples (Figure 2f),
with an increase of 2.31-, 1.66-, and 2.03-fold, respectively,
as compared with those in NHKs (densitometry data not
shown). Id-1 expression did not vary except for the TTD
sample (Figure 2f).
Thus, Bmi-1 decrease correlates with p16INK4a increase
and stem cell depletion in epidermal tissue. Taken together
these data suggest that the age-related increase of p16INK4a
expression in primary human keratinocytes could be princi-
pally attributed to the modulation of Bmi-1 levels. Ets-1
upregulation might cooperate with Bmi-1 downregulation
in inducing p16INK4a increase in premature skin aging
syndromes.
Expression of p16INK4a regulators in epidermal clonal evolution
In human keratinocyte cultures, clonal evolution drives
replicative senescence. Recently, we reported that Bmi-1
downregulation correlates with p16INK4a upregulation during
keratinocyte replicative senescence (Maurelli et al., 2006).
Here, we investigated the expression of additional p16INK4a
regulators during serial passages. Both Ets-1 and Id-1 protein
expression decreased during in vitro clonal conversion
(Figure 3a).
It has been shown that histone deacetylase inhibitors, such
as trichostatin-A (TSA), induce a phenotype reminiscent of
replicative senescence in human fibroblasts by a p16INK4a-
dependent mechanism (Munro et al., 2004). By examining
the influence of TSA treatment on the expression of p16INK4a
and its regulators in human keratinocytes, we observed that
TSA induced a senescent-like phenotype of this cell type
(Figure 3b). A dose-dependent increase of p16INK4a expres-
sion and a parallel downregulation of Bmi-1 was already
evident following treatment with 50 nM TSA (Figure 3c). As
shown in Figure 3c, decreased expression of Id-1 and Ets-1
was also detected, but only at higher TSA doses (100 and
150nM). Analysis of the p14ARF/p53 pathway after TSA
treatment showed that p14ARF was barely detectable, p53
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expression slightly decreased with TSA at 50–100 nM, and
p21Waf1 did not vary significantly (Figure 3d).
Clonal evolution also occurs in vivo when a stem cell
daughter is committed to differentiate in TA and postmitotic
cells (Barrandon and Green, 1987b; Alonso and Fuchs,
2003). Stem and TA keratinocytes can be identified according
to their different proliferative characteristics in vitro. On the
basis of the percentage of aborted colonies, three types of
keratinocyte clones can be distinguished: the holoclone
(giving rise to 0–5% of aborted colonies), which is considered
the keratinocyte stem cell, and the meroclone (5–95%
aborted colonies) and paraclone (100% aborted colonies),
which are young and old TA cells, respectively (Barrandon
and Green, 1987b; Larcher et al., 2007). A decrease of
holoclone percentage with aging has also been reported
(Barrandon and Green, 1987b). We investigated the expres-
sion of p16INK4a and its regulators in different keratinocyte
clonal types. Clonal analysis of a primary keratinocyte culture
showed 10% of holoclones, 32.5% of meroclones, and
57.5% of paraclones. Clones were classified on the basis of
the percentage of aborted colonies. Each clone (identified in
Figure 3e, with the aborted colony percentage at the time of
cell seeding) was then subcultivated for one passage. The
obtained cultures, which have undergone several additional
cell doublings compared with the original clone, were
analyzed by immunoblotting (Figure 3e). p16INK4a was
undetectable in cultures formed by cells with a mean cell
diameter of 8–10 mm and derived from clones presenting 0.7,
1.7, 2.4, 5.5, and 5.7% of aborted colonies. On the contrary,
p16INK4a was expressed in cultures with a mean diameter of
32–40 mm and derived from clones showing 15.7, 18.6, 81,
and 90% of aborted colonies. Thus, p16INK4a expression was
seen only when clonal conversion was almost completed.
Interestingly, Bmi-1 expression was inversely correlated
with aborted colony percentage. Namely, Bmi-1 levels were
higher in cultures derived from clones presenting 0.7, 1.7,
and 2.4% of aborted colonies, whereas they were lower in
cultures from the remaining clones (Figure 3e and f). In
particular, densitometric analysis showed that the average
Bmi-1 expression value of the three clones bearing the lowest
percentage of abortive colonies (0.7–2.4%) was significantly
higher (Po0.01) than that of the remaining six clones
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analysis was performed on primary keratinocytes (K69, 16 years) as described under Materials and Methods. p16INK4a, Bmi-1, Ets-1, and Id-1 expression
was assessed by western blotting using cell extracts prepared from keratinocyte cultures obtained from different clones. The corresponding paraclone percentage
value is reported in each lane. HeLa cells (H) were used as positive control of p16INK4a. (f) The OD of the autoradiographic bands (western blot shown in
panel e) was quantified and normalized to GA3PDH for equal loading.
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(Figure 3f). Of note, Bmi-1 appeared already downregulated
in cultures presenting just a slight decrease of clonogenic
potential (5.5 and 5.7% of aborted colonies) in the absence of
any senescent phenotype. Ets-1 and Id-1 expression did not
correlate with clonal type or p16INK4a expression.
Altogether these data strengthen the concept that modula-
tion of Bmi-1 expression levels is crucial for p16INK4a
regulation during clonal conversion both in vitro and in vivo.
Oxidative stress induction and p16INK4a regulator expression
ROS accumulation has been associated with mammalian
aging (Dro¨ge and Schipper, 2007). Thus, we analyzed
p16INK4a-regulator expression following treatment with two
ROS inducers H2O2 and Ras oncogene. Exposure of primary
human keratinocytes in complete culture medium (EGFþ ) to
H2O2 doses ranging from 125 to 6mM for 24 hours did not
significantly alter cell viability (data not shown) and did not
induce clonal conversion or increase of p16INK4a expression
(Figure 4a and b). However, a modest decrease of clono-
genicity and proliferation was observed at the highest doses
(data not shown). Bmi-1 expression decreased after 4mM
H2O2 treatment, whereas increase of p21
Waf1 expression was
observed already following 2mM H2O2 treatment (Figure 4b),
suggesting that the decrease of cell proliferation could be
correlated to the p21Waf1 blocking effect on the cell cycle.
Treated keratinocytes were able to recover their proliferation
ability with time, as indicated by gradual increase of cell
number following the end of H2O2 exposure (data not shown).
To exclude any interference of EGF or other growth
factors/hormones on ROS intermediate production, in a
further set of experiments H2O2 treatment and subsequent
culturing of keratinocytes were performed in medium without
EGF (EGF) or growth factors (starvation medium). Cells
were then collected at different times. These treatments
resulted in clonal conversion of keratinocytes (Figure 4c), and
in a marked decrease of cell number (Figure 4d, red vs blue
line), which was partially due to decrease of cell viability
24 hours after the end of the treatment (data not shown). CFE
assays performed 2 days after H2O2 treatment of EGF or
starved cultures showed a striking decrease of clonogenicity
(Figure 4e). Extremely low clonogenicity was maintained for
at least 6 days after treatment (Figure 4e). In parallel, we
observed a time-dependent increase of p16INK4a expression,
starting 3 days after H2O2 exposure (Figure 4f). In addition,
Bmi-1 expression decreased and Ets-1 expression increased
already 2 days after treatment, whereas Id-1 expression did
not vary during time (Figure 4f). Interestingly, p21Waf1
expression increased 2 days after H2O2 treatment (Figure 4f).
Several oncogenes, such as oncogenic Ras, have been
reported to induce marked ROS accumulation (Mitsushita
et al., 2004). In addition, Ras activation in fibroblasts leads to
increased Ink4a/Arf expression following ERK-mediated
activation of Ets-1/2 (Ohtani et al., 2001). Using a retroviral
infection method, we transduced primary keratinocyte
cultures with oncogenic Ras (Ras-V12), known to induce a
senescent phenotype in these cells (Lazarov et al., 2002).
Seventy-two hours after infection, cells were collected and
western blot experiments were performed. As shown in
Figure 4g, p16INK4a expression increased and Bmi-1
expression decreased following Ras overexpression. Densito-
metric analysis showed a 0.69-fold decrease of Bmi-1
expression and a slight increase of both Ets-1 and Id-1
(2.14- and 1.32-fold, respectively; data not shown).
Thus, oxidative stress induces an immediate increase of
p21Waf1 expression, while concomitant growth factor depri-
vation is required to induce p16INK4a upregulation. This
increase of p16INK4a expression might be due to concomitant
Ets-1 upregulation and Bmi-1 downregulation. Of note,
keratinocytes undergo clonal conversion solely when
p16INK4a upregulation is induced.
Serum/stromal cell deprivation and p16INK4a-regulator
expression
Each keratinocyte strain was cultivated in parallel on feeder
layer with complete keratinocyte medium and without feeder
layer in serum-free medium. The latter culture condition
induced abrupt clonal conversion characterized by increase
of p16INK4a expression (Figure 4h). This increase correlated
with a decrease of Bmi-1 and Id-1 expression and increase of
Ets-1 (Figure 4h). These data strengthen the notion that Bmi-1
downregulation and Ets-1 upregulation could work in concert
in keratinocyte premature senescence to induce p16INK4a-
mediated clonal conversion.
p16INK4a-promoter regulation by Ets-1, Id-1, and Bmi-1 in
primary human keratinocytes
It has been reported that Id-1 and Ets-1 levels directly regulate
p16INK4a promoter in human fibroblasts (Ohtani et al., 2001).
We investigated p16INK4a-promoter regulation in primary
human keratinocytes by co-transfecting the cells with a
reporter plasmid containing luciferase driven by p16INK4a
promoter, and a plasmid containing Ets-1, Id-1 or Bmi-1.
Luciferase activity was measured 48 hours later. As shown in
Figure 5a, increasing the amount of Ets-1 resulted in a
significant dose-related activation of p16INK4a-promoter
activity. Id-1 (Figure 5b) and Bmi-1 (Figure 5c) induced a
reduction of p16INK4a-promoter activity, suggesting that both
proteins might act as negative competitors of Ets-1.
Co-transfection of Id-1 or Bmi-1 appeared to affect the ability
of Ets-1 to activate the p16INK4a promoter. Indeed, Id-1 and
Bmi-1 reduced the Ets-1-induced p16INK4a promoter activa-
tion in a dose-dependent manner (Figure 5d and e).
This finding provides the first evidence that Bmi-1 and Id-1
are able to inhibit p16INK4a-promoter activation mediated by
Ets-1 in primary human keratinocytes.
p16INK4a-promoter activation in epidermal aging
To evaluate the basal activity of the p16INK4a promoter in
keratinocytes from elderly versus young individuals, cells
were transfected with a reporter plasmid containing lucifer-
ase driven by the p16INK4a promoter or the pGl2 basic as
control, and luciferase activity was measured 48 hours later.
As shown in Figure 5f, p16INK4a-promoter activity did not
vary significantly among young individuals (columns 1–3).
The highest p16INK4a-promoter activities were observed in
elderly subjects (Figure 5f, columns 4–8) and in three cases
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(Figure 5f, columns 6–8) the increase was statistically
significant when compared with those in young individuals.
Of note, in elderly donors p16INK4a-promoter activity showed
positive and negative correlation with p16INK4a (compare
Figures 5f to 1b) and Bmi-1 (compare Figures 5f to 2e)
expression levels, respectively. In fact, elderly subjects with
the lowest Bmi-1 expression showed highest p16INK4a-
promoter activity. On the other hand, no correlation could
be found between p16INK4a-promoter activity and Ets-1 or
Id-1 expression (compare Figures 5f to 2e).
K7
9 (+
FL)
P1
 (–F
L)
P1
 (+F
L)
K7
9 (–
FL)
Ets1
Id1
GA3PDH
Bmi-1
GA3PDH
C 2 m
M
Bmi-1
Ets1
Id1
GA3PDH
V RasV12
Bmi-1
p16INK4a p16INK4a
p16INK4a
6 m
M
4 m
M
H
Ets1
Id1
GA3PDH
Bmi-1
p16INK4a
C
2 d 5 d3 d 6 d
H2O2
p21
H
p21
C
Recovery 2d
H2O2 (4 mM, 24 h )
Recovery 2d
St
EGF-
C (recovery 0d)
H2O2(6 mM, 24 h — recovery 0d)
Time (days)
C (recovery 3d)
H2O2(4 mM, 24 h — recovery 3d)
Recovery 6d
2 3 4 5 6
0
N
o.
 
o
f c
el
ls
5,000,000
4,000,000
3,000,000
2,000,000
1,000,000
Figure 4. Expression of p16INK4a and its regulators in premature senescence. (a, b) Keratinocyte cultures were treated for 24 hours with H2O2 (2–6mM) in
complete medium containing EGF and growth factors (EGFþ ). Cell colonies were photographed. Bars¼ 300m. p16INK4a, Bmi-1, and p21Waf1 expression
was assessed by western blotting using cell extracts prepared from these keratinocyte cultures. HeLa cells (H) were used as positive control of p16INK4a.
Results are representative of two cell strains (K69 and K79). (c–f) Keratinocyte cultures were treated with H2O2 (4mM) for 24 hours in medium without EGF
(EGF) or without growth factors (starvation medium, St). Cell colonies were photographed (panel c, bars¼ 300 m). The medium was then removed, and
fresh medium (EGF or St) was added to allow cell recovery. Cells were collected at different recovery times (2–6 days). The total number of cells obtained from
each mass culture was plotted against the recovery time (blue line, untreated cells; red line, H2O2-treated cells) (d). CFE assays from control and treated
keratinocytes were performed at the indicated times: CFE from H2O2-treated cells collected 2 and 6 days after treatment, and from parallel untreated control cell
cultures collected at day 2 (e). p16INK4a, Bmi-1, Ets-1, p21Waf1, and Id-1 expression was assessed by western blotting (f) using cell extracts
prepared from the starved keratinocyte cultures at each time of collection. HeLa cells (H) were used as positive control for p16INK4a. Results are representative of
two cell strains (K69 and K79) and of both culture conditions (EGF and St). Error bars represent mean±SD. (g) Primary keratinocyte cultures (K79) were
transduced with oncogenic Ras (Ras-V12), and cells were collected 72 hours after infection. p16INK4a, Bmi-1, Ets-1, and Id-1 expression was assessed by western
blotting using cell extracts prepared from these keratinocyte cultures. (h) Keratinocyte cultures (K79 and P1) were performed both on the feeder layer with
normal keratinocyte medium (þ FL) and without the feeder layer with serum-free medium (FL). p16INK4a, Bmi-1, Ets-1, and Id-1 expression was assessed by
western blotting using cell extracts prepared from these keratinocyte cultures.
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Altogether these results demonstrate that the increase in
p16INK4a expression during aging is regulated at the
transcriptional level. Moreover, Bmi-1 protein levels seem
to be critical in the modulation of p16INK4a transcription in
primary human keratinocytes during aging.
Effects of Bmi-1 overexpression on p16INK4a-promoter activity
and protein expression in aged and diseased keratinocytes
To assess the functional relevance of Bmi-1 in aged and
diseased keratinocyte cultures, we stably transduced primary
cells from two old donors (Kp1 and Kp3) and an XP-C patient
(XP-C2) with an empty vector or a cDNA encoding Bmi-1,
using a retroviral infection method. As expected, we
observed irregular colonies with enlarged and flattened cells
in all empty vector-transduced keratinocyte cultures, similar
to those present in normal aged and diseased keratinocyte
cultures (Figure 6a, Kp1–V). Interestingly, colonies with
regular boundaries mainly composed by small proliferating
cells appeared in all Bmi-1-transduced keratinocyte cultures
(Figure 6a, Kp1–Bmi1). CFE assay showed a low colony-
forming ability in empty vector-transduced cultures, as
expected (Figure 6b, V). In fact, the CFE values of XP-C2–V,
Kp1–V, and Kp3–V were 4.2, 1.1, and 0.5%, respectively. In
addition, most of the colonies were paraclones and their
percentage was 76, 91, and 80% in XP-C2–V, Kp1–V, and
Kp3–V cultures, respectively. In contrast, cultures increased
their clonogenic capacity subsequent to Bmi-1 transduction
(Figure 6b, Bmi-1). The CFE values of XP-C2–Bmi1,
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Figure 5. p16INK4a promoter activation in epidermal aging. (a–c) A reporter plasmid containing the p16INK4a promoter and a plasmid containing Ets-1 (a),
Id-1 (b), or Bmi-1 (c) were co-transfected with a standard amount of the CMV-lacZ control plasmid. Cells were harvested 48 hours after transfection and
assayed for luciferase and b-galactosidase. Luciferase activity was normalized to the corresponding b-galactosidase activity. Promoter activities were calculated
using the empty vector control (column 1) as reference. The promoter:Ets-1 ratio was 1:0.25 (column 2), 1:0.5 (column 3), 1:1 (column 4), 1:2 (column 5),
and 1:3 (column 6). The promoter:Id-1 ratio was 1:1 (column 2), 1:2 (column 3), and 1:3 (column 4). The promoter:Bmi-1 ratio was 1:1 (column 2), 1:2 (column
3), and 1:3 (column 4). (d, e) A reporter plasmid containing the p16INK4a promoter, a plasmid containing Ets-1 (ratio 1:2), and a plasmid containing Id-1
(d) or Bmi-1 (e) were co-transfected with a standard amount of the CMV-lacZ control plasmid. Promoter activities were calculated using the empty vector
control (column 1) as reference. The promoter:Ets-1 ratio was 1:2 (column 2). The promoter/Ets-1 Id-1 ratio was 1:0.5 (column 3), 1:1 (column 4), 1:2 (column 5),
and 1:3 (column 6). The promoter/Ets-1:Bmi-1 ratio was 1:0.5 (column 3), 1:1 (column 4), 1:2 (column 5), and 1:3 (column 6). (f) Keratinocytes from elderly
and young individuals were co-transfected with a reporter plasmid containing the p16INK4a promoter or the pGl2 basic as control, and a standard amount
of the CMV-lacZ control plasmid. Promoter activities were calculated using the empty vector as control and normalized to young individual PR5 (column 1).
Other samples were PR3 (column 2), K124 (column 3), K111 (column 4), K115 (column 5), Kp1 (column 6), Kp3 (column 7), and Kp4 (column 8). Transfection
assays were performed in triplicate. Error bars represent mean±SD. *Po0.05, **Po0.01 compared with column 2 in e and to column 1 in all other panels.
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Kp1–Bmi1, and Kp3–Bmi1 reached 12.3, 6.6, and 6.5%,
respectively. Of note, the paraclone percentage was reduced
to 30.8, 16.6, and 44.6% in XP-C2–Bmi1, Kp1–Bmi1, and
Kp3–Bmi1 cultures, respectively.
The transduced cells were then subcultivated and
further experiments were performed. To evaluate the basal
activity of the p16INK4a promoter in aged (Kp1) and diseased
(XP-C2) keratinocytes following Bmi-1 overexpression, Bmi-1
or empty vector-transduced keratinocyte cultures were
transfected with a reporter plasmid containing luciferase
driven by the p16INK4a promoter or the pGl2 basic as control,
and luciferase activity was measured 48 hours later. As
shown in Figure 6c, the p16INK4a-promoter activity was
significantly inhibited (Po0.01) in cells overexpressing Bmi-1.
Particularly, a decrease of 72 and 36% was observed in
keratinocyte cultures from the old donor and the XP-C patient,
respectively.
To evaluate p16INK4a expression following Bmi-1 over-
expression, Bmi-1 or empty vector-transduced keratinocyte
cell cultures (Kp1, Kp3, and XP-C2) were subjected to
western blot analysis. In keeping with the promoter-activity
data, p16INK4a expression decreased following Bmi-1 over-
expression in all the cultures (Figure 6d).
Altogether these results demonstrate that Bmi-1 is able to
regulate p16INK4a expression at the transcriptional level in
aged and diseased keratinocytes. Of note, Bmi-1 levels are
critical in the modulation of the clonogenic ability and the
clonal conversion in those cultures.
DISCUSSION
One of the main features of aging is progressive depletion of
the stem cell pool, probably due to cell senescence. Recent
data suggest that expression of p16INK4a induces an age-
dependent decrease in the proliferative capacity of hemato-
poietic and neural stem cells, and unipotent progenitors of
pancreatic b-cells (Kim and Sharpless, 2006, and reference
herein). Nevertheless, alteration of p53 activity has been
reported to also affect stem cell number, proliferative
potential, and hematopoiesis in older organisms (Dumble
et al., 2007).
To get insight into the mechanisms of human epidermal
aging, we used primary human keratinocyte cultures from
young versus old donors, and from young patients with
inborn defects leading to precocious senescence (XP-C, TTD,
and progeria), as in vitro models of physiological and
premature aging, respectively.
Bmi-1
p16INK4a
GA3PDH
Kp
1-V
Kp1-V Kp1-Bmi1
XP
-C
2-B
mi
1
XP
-C
2-V
Kp
3-B
mi
1
Kp
3-V
Kp
1-B
mi
1
Kp
1-V
XP
-C
2-B
mi
1
XP
-C
2-V
Kp
1-B
mi
1
R
el
at
ive
 lu
ci
fe
ra
se
 a
ct
iv
ity
V
Bmi-1
72%
36%
**
**
XP-C2 Kp1 Kp3
1
0.8
0.4
0.2
0
0.6
Figure 6. Effects of Bmi-1 on p16INK4a-promoter activity and protein expression in aged and diseased keratinocytes. (a) Keratinocyte cultures from two
old donors and an XP-C patient were transduced with an empty vector (V) and the Bmi-1 cDNA using a retroviral method. Isolated colonies were
photographed. Left: empty vector-transduced Kp1 culture. Right: Bmi-1-transduced Kp1 culture. Bars¼ 300m. (b) CFE assay was performed on empty
vector- and Bmi-1-transduced aged (Kp1 and Kp3) and diseased (XP-C2) keratinocytes. (c) Empty vector- and Bmi-1-transduced aged (Kp1) and diseased (XP-C2)
keratinocytes were co-transfected with a reporter plasmid, containing p16INK4a promoter or the pGl2 basic, and a standard amount of the CMV-lacZ control
plasmid. The p16INK4a-promoter activities were normalized to the pGl2 basic activities. Then, the promoter activity decrease following Bmi-1 overexpression
was calculated using as a reference that of the corresponding empty vector cells. Transfection assays were performed in triplicate. Error bars represent
mean±SD. **Po0.01 compared with the vector. (d) p16INK4a and Bmi-1 expression was assessed by western blotting using cell extracts prepared from
XP-C2-, Kp1-, and Kp3-transduced cultures.
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p16INK4a level increases in physiological/premature aging of
human epidermis
p16INK4a expression is detectable only in first-passage
primary keratinocytes from elderly subjects, in particular
being constantly present in individual older than 70 years. In
contrast, the expression levels of p14ARF, p53, and its
transcriptional target, p21Waf1, do not vary significantly in
the corresponding cultures from young and elderly donors.
Interestingly, an inverse correlation between p16INK4a and
p63 levels is shown and confirmed by the evaluation of
proliferative potential. Remarkably, in first-passage keratino-
cyte cultures there is a strong positive correlation between
stem cell depletion and early p16INK4a expression, indicating
the presence of senescent cells in the epidermis from old
donors. Furthermore, the percentage of paraclones increases
more rapidly during subcultivation of cultures precociously
expressing high levels of p16INK4a. Of note, the presence of
higher paraclone percentage and levels of p16INK4a in
keratinocyte cultures from old donor photoexposed skin as
compared with that in non-photoexposed skin indicates that
chronic UV exposure contributes to keratinocyte senescence.
Finally, a link between senescence and differentiation
process in vivo is suggested by the increased expression of
a differentiation marker, such as involucrin, in cultures from
old donors.
Investigations of young patients affected by precocious
skin senescence syndromes suggest that premature aging is
associated with the same molecular effectors observed during
physiological aging. In particular, early expression of
p16INK4a strongly correlates with increased paraclone
percentage and p63 downregulation.
Altogether these findings show that p16INK4a is the major
marker of both advanced physiological and premature aging
in human keratinocytes. What is more is that p16INK4a
upregulation always correlates with stem cell depletion in
epidermal tissue in both conditions.
Bmi plays a key role in p16INK4a upregulation associated with
epidermal stem cell depletion
Three candidate molecules, that is, Bmi-1, Ets-1, and Id-1, are
potentially responsible for the marked accumulation of
p16INK4a in epidermal tissue with aging. Bmi-1, a member
of the family of PcG proteins, is a repressor of the Ink4a/Arf
locus and is critical for the maintenance of adult stem cells in
some tissues (Park et al., 2004). Bmi-1 is overexpressed in
tumor cells and its overexpression in mammary epithelial
cells induces immortalization by enhanced telomerase
activity (Dimri et al., 2002). On the other hand, the age-
related increase of p16INK4a expression in mouse and rat
tissues has been attributed mainly to the expression of Ets-1,
a member of the Ets family of transcription factors
(Krishnamurthy et al., 2004). Ets-1 is also produced by a
variety of solid tumors, including epithelial tumors (Dittmer,
2003). Id-1 is a transcriptional repressor of p16INK4a, over-
expressed in several primary tumors and able to promote cell
proliferation (Ohtani et al., 2001; Ling et al., 2005). The
marked increase in p16INK4a levels observed in senescent
human fibroblasts is consistent with the reciprocal reduction
of Id-1 and accumulation of Ets-1 (Ohtani et al., 2001).
However, although Id-1 overexpression is able to extend the
lifespan of keratinocytes and fibroblasts, it does not prevent
the onset of replicative senescence (Nickoloff et al., 2000;
Alani et al., 2001).
Here, we show that Bmi-1 is expressed in first-passage
keratinocyte cultures obtained from young donors, whereas it
is decreased in primary keratinocytes from old subjects and
from patients affected with premature aging syndromes.
These in vitro data are confirmed by immunohistochemical
analysis performed on skin from young and old donors,
and are in agreement with previously published data
(Ressler et al., 2006). Of note, there is an inverse correlation
between Bmi-1 expression and p16INK4a levels/stem cell
depletion in epidermal tissue. Moreover, Bmi-1 expression is
slightly more downregulated in photoexposed area versus
non-photoexposed areas of the same old donor. Using a
luciferase-reporter assay, we confirm that Bmi-1 represses
p16INK4a-promoter activity and inhibits Ets-1-mediated
p16INK4a upregulation in primary human keratinocytes.
Despite the ability of Ets-1 and Id-1 to modulate the
p16INK4a promoter, no correlation between their expression
and p16INK4a expression or stem cell depletion during
chronological aging could be detected.
Altogether our data suggest that the age-related increase of
p16INK4a expression in primary normal keratinocytes, which
correlates with stem cell depletion, may be principally
attributed to the modulation of Bmi-1 levels. However, most
of the cultures from patients with premature aging syndromes
show an upregulation of Ets-1, which might be related to the
decreased expression of p53, a repressor of Ets-1(Iotsova
et al., 1996). Although referring to a limited number of
samples, this finding suggests that Ets-1 upregulation
might cooperate with Bmi-1 downregulation in inducing
p16INK4a increase in premature aging.
In epidermal tissue, clonal conversion occurs in vivo and
the resulting TA keratinocytes can be distinguished from stem
cells based on their proliferative and clonogenic character-
istics in vitro. By analyzing different keratinocyte clonal types
directly obtained from a skin biopsy, we show that p16INK4a
expression is detectable only in those cultures in which
clonal conversion is almost completed. Interestingly, the
highest Bmi-1 expression is seen in cultures from clones
presenting the lowest percentage of aborted colonies. Of
note, Bmi-1 is already downregulated in young meroclone
cultures presenting a slight decrease of clonogenic potential
before the appearance of an overt senescent phenotype.
These clonal data are in agreement with the upregulation of
p16INK4a and downregulation of Bmi-1 in first-passage
cultures from old donors where clonal conversion is already
taking place. Reminiscent of what is observed in young
meroclone cultures, an initial Bmi-1 decrease was also
detected in adult donor (over 40 years), first-passage
keratinocytes, which show a decrease of p63 expression
and clonogenic potential, without increase of p16INK4a levels
or paraclone percentage. Altogether these data point to a
crucial role of Bmi-1 downregulation in inducing loss of
clonogenic potential. Solely when p16INK4a upregulation is
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also induced, clonal conversion is accomplished resulting in
stem cell depletion. These findings lead us to hypothesize
that Bmi-1 downregulation in epidermal tissue could act also
on different pathways to induce some p16INK4a-independent
aging features. Indeed, in aged animal models, p16INK4a loss
does not completely eliminate the effects of aging and is
associated with a progressive reduction in specific tissue
regenerative capacity that has been ascribed to p16INK4a-
independent aging (Kim and Sharpless, 2006).
Bmi-1 levels are critical in p16INK4a regulation during in vitro
keratinocyte replicative and premature senescence
The ability of Ets-1 and Id-1 to modulate p16INK4a-promoter
activity prompted us to investigate the possible involvement of
these regulators in replicative senescence, as it mimics some of
the key features of intrinsic epidermal aging, and premature
senescence induced by different stresses, which are typical of
both intrinsic and extrinsic aging (eg, ROS accumulation).
Replicative senescence is an irreversible process accom-
panied by changes in gene expression that result in part from
alterations in the histone acetylation machinery (Munro et al.,
2004). We show that treatment with a histone deacetylase
inhibitor (TSA) induces a senescent-like phenotype in kerati-
nocytes by upregulation of p16INK4a, accompanied by Bmi-1
downregulation and, at high doses, also by Ets-1 and Id-1
decrease. No increase of p14Arf and p21Waf1 was observed.
Overall increasing TSA dosage appears to mimic the molecular
pattern observed in senescent keratinocyte cultures, in which
clonal conversion occurs during serial cultivation. Therefore,
Bmi-1 downregulation could drive keratinocyte clonal conver-
sion and the subsequent Id-1 downregulation could be
involved in maintaining the senescence state. Further studies
are needed to explain the molecular basis of the Ets-1 decrease.
Finally, these findings strengthen the notion that modula-
tion of Bmi-1 levels is critical in p16INK4a regulation during
clonal conversion both in vivo and in vitro.
Premature senescence is induced by several stress stimuli,
including ROS. When ROS levels overcome the antioxidant-
system activity, oxidative stress results and several cellular
constituents are damaged. Normally, oxidized molecules are
degraded by the proteasome or eliminated by pathways that
trigger DNA repair. However, an age-related decline of the
efficiency of these defense systems has been described in
some tissues (Widmer et al., 2006; Dro¨ge and Schipper,
2007; Rossi et al., 2007). Oxidative stress causes loss of
proliferative capacity and induction of senescence in human
fibroblasts in vitro by p21Waf1 and p53 upregulation. In this
cell system, p16INK4a expression is induced only as a
secondary and subsequent event (Chen et al., 2004).
Following H2O2 treatment in EGFþ medium, we do not
observe keratinocyte clonal conversion but rather a decrease
of culture clonogenicity and cell proliferation that is
paralleled by p21Waf1 upregulation. Thus, in primary human
keratinocytes, p21Waf1 increase seems to correlate with
cell-cycle arrest instead of premature senescence. H2O2
treatment induces downregulation of Bmi-1, in keeping with
data by Nakanuma and co-workers (2006) in a different
epithelial cell type.
However, EGF is a potent antagonist of ROS-intermediate
production by keratinocytes (Heck et al., 1992) and insulin
protects some cell types from cytotoxicity and apoptotic
death induced by oxidative stress (Baregamian et al., 2006).
Oxidative stress experiments performed in absence of EGF or
other growth factors/hormones result in keratinocytes
clonal conversion in addition to a decrease of cell number
and viability. At molecular level, p21Waf1 upregulation is
the primary event, followed by p16INK4a upregulation, which
temporarily matches the onset of clonal conversion,
suggesting a role of this protein in the maintenance of the
senescent state; in parallel, Bmi-1 expression decreases and
Ets-1 expression increases.
ROS accumulation is also induced by several oncogenes,
such as oncogenic Ras (Irani et al., 1997; Mitsushita et al.,
2004), which determines premature cellular senescence by
upregulating p16INK4a (Serrano et al., 1997). In human
fibroblasts, Ets proteins are the transmitters of Ras–Raf–MEK
pathway to p16INK4a (Ohtani et al., 2001). Here, we observe
that overexpression of oncogenic Ras (Ras-V12) induces
clonal conversion and p16INK4a expression increase in
primary human keratinocytes. p16INK4a upregulation corre-
lates with Ets-1 upregulation and Bmi-1 downregulation,
similarly to what is observed after H2O2 treatment
concomitant to growth factor deprivation.
In vivo, the age-related changes affecting the dermal–epi-
dermal junction lead to reduced surface contact between the
epidermis and dermis, and decreased exchange of nutrients.
The progressive decline of growth factors and hormones plays
a role in both epidermal and dermal aging. Moreover, the aged
dermis appears hypocellular, with fewer fibroblasts (Yaar,
2006). The crucial role of the fibroblast feeder layer as well as
hormones and growth factors for optimal growth of human
keratinocytes in vitro has been shown several years ago
(Rheinwald and Green, 1975; Barrandon and Green, 1987a).
Cultivation of primary human keratinocytes in serum-free
medium without growth factors and feeder layer represents a
condition of striking nutrient decrease and stromal cell
deprivation, thus magnifying physiological modifications
occurring during skin aging. These culture conditions result
in abrupt clonal conversion characterized by p16INK4a expres-
sion increase. This increase correlates with decrease of Bmi-1
and Id-1, and increase of Ets-1 expression.
Thus, oxidative stress and serum/feeder layer deprivation
appear able to induce premature senescence accompanied
by abrupt onset of clonal conversion. Under these conditions,
p16INK4a upregulation might be ascribed to synergic action of
Bmi-1 and Ets-1.
Bmi-1 overexpression modulates both p16INK4a expression at
the transcriptional level and clonal conversion in aged and
diseased keratinocytes
Luciferase-reporter assay experiments confirm that the
increase in p16INK4a expression in aged cells is regulated at
the transcriptional level and this modulation seems to be due
to Bmi-1 protein levels.
Ectopic expression of Bmi-1 demonstrates that this protein
is able to modulate both p16INK4a levels and keratinocyte
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clonal conversion in aged and diseased primary human
keratinocytes. Specifically, Bmi-1 overexpression inhibits
p16INK4a-promoter activity in transduced cell cultures
determining a decrease of the protein expression. Following
p16INK4a downregulation, Bmi-1 transduced cultures present
a delay of clonal conversion, as attested by both colony
morphology and CFE assays.
Altogether our in vivo and in vitro data support a primary
role of Bmi-1 downregulation in enforcing aging in primary
human keratinocytes.
MATERIALS AND METHODS
Cell and culture conditions
Primary keratinocyte cultures were established from biopsies of
non-photoexposed areas of the skin from 29 healthy donors (18
young subjects, 2–45 years; 11 old subjects, 60–82 years) and four
patients with hereditary disorders characterized by skin precocious
aging, namely progeria (one case), TTD (one case), and XP-C (two
cases). Written informed consent was obtained from adult subjects
and from minors’ parents. Procedures were performed in accordance
with the ethical standards of the Committee on Human Experi-
mentation of Istituto Dermopatico dell’Immacolata. The study was
conducted according to the Declaration of Helsinki Principles.
The TTD patient showed normal cellular response to UV and no
mutation in the TTDN1 gene, suggesting the presence of a defect in
one of the still unidentified gene(s) responsible for the non-
photosensitive form of TTD (Botta et al., 2007). Both XP patients
(XP26PV and XP38PV) showed altered cellular response to UV and
were assigned to the XP-C group. Clinical, cellular, and molecular
data on XP26PV are reported by Chavanne et al. (2000).
Characterization of the mutation of the progeria patient is under
investigation. For two healthy subjects, primary keratinocyte cultures
were also established from biopsies of photoexposed areas of
the skin.
Keratinocytes were cultivated on a feeder layer of lethally
irradiated 3T3-J2 cells (a gift from Professor H Green), as described
by Barrandon and Green (1987a). For serial propagation, cells were
passaged at the stage of subconfluence, until they reached
senescence (Dellambra et al., 2000).
CFE and cell generations
For CFE assay, cells (100–1,000) from each biopsy and from each cell
passage were plated onto 3T3 feeder layers and cultured as above.
Colonies were fixed 14 days later, stained with rhodamine-B, and
scored under a dissecting microscope. Total colonies were
calculated as a percentage of total plated cells (number of
colonies 100/number of cells plated). The aborted colonies were
counted as described by Barrandon and Green (1987b) and
Dellambra et al. (2000).
The number of cell generations was calculated using the
following formula: x¼ 3.322 log N/No., where N is the total number
of cells obtained at each passage and No. is the number of
clonogenic cells. The number of clonogenic cells, which was
determined separately in parallel dishes at the time of cell passage,
was calculated from CFE data. The cumulative number of cell
generations per passage was plotted against total time in culture.
Clonal analysis was performed as described by Barrandon
and Green (1987b) and Pellegrini et al. (2001). Briefly, single
cells were inoculated onto multi-well plates containing a feeder
layer of 3T3 cells. After 7 days of cultivation, clones were identified
with an inverted microscope. One out of four of each clone
was transferred into a Petri dish. The dish was fixed 9–12 days
later and stained with rhodamine-B for classification of clonal
type, which was determined by the percentage of terminal colonies
formed by the progeny of the founding cell. When 0–5% of
colonies was terminal, the clone was scored as holoclone.
When more than 95% of the colonies were terminal, the clone
was classified as paraclone. When more than 5%, but less than
95% of the colonies were terminal, the clone was classified as
meroclone.
Retrovirus-mediated gene transfer
L(RasV12) SN was constructed by cloning the full-length RasV12
cDNA (a gift from Pablo Rodriguez-Viciana, University of California,
San Francisco, CA) into EcoRI site of pLXSN. L(Bmi-1) SN was
constructed by cloning the full-length Bmi-1 cDNA (a gift from GP
Dimri, Evanston, IL) into EcoRI/XhoI sites of pLXSN. The Am12/
L(RasV12) SN, L(Bmi-1) SN, and Am12/LXSN (named V in the text)
producer cell lines were generated by the trans-infection protocol, as
described by Mathor et al. (1996). Producer cell lines showed a viral
titer of 1 106 cfuml1. Keratinocyte infections were performed as
described by Mathor et al. (1996). Subconfluent cultures were used
for further analysis.
Western analysis and immunohistochemistry
For immunoblots, keratinocytes were extracted on ice by lysis with
radioimmunoprecipitation assay buffer and equal amounts of
samples (50 mg) were electrophoresed on 7.5–12.5% SDS-polyacry-
lamide gels. Western blot was performed as described by Dellambra
et al. (2000), using the following antibodies: anti-p16INK4a (N20),
anti-p63 (4A4), anti-p53 (DO-1), anti-Ets-1 (N276), and anti-Id-1
(C20) from Santa Cruz Biotechnology Inc. (Santa Cruz, CA); anti-
Bmi-1 from Upstate (Scotland, UK); p14ARF from Oncogene (Cam-
bridge, MA); p21Waf1 (a gift from K Helin, University of Copenhagen,
Denmark).
Immunohistochemistry was performed as described by
Dellambra et al. (2000), using anti-Bmi-1 antibody. Antigen retrieval
was performed by boiling sections in target retrieval solution (DAKO
Cytomation, Hamburg, Germany) in a microwave oven for 2minutes
and by treating them with 0.1% trypsin for 10 seconds at room
temperature.
Transient DNA transfection and luciferase-reporter assay
The reporter vector pGl2basic containing 869 nucleotides upstream
of the p16INK4a translation start site (named p16INK4a promoter), the
empty vector pGl2basic, the pcDNA3–Eta-1, and pcDNA3–Id-1 were
kind gifts from E Hara (University of Tokushima, Japan). Bmi1
c-DNA was kindly provided by GP Dimri (Evanston, IL).
Primary human keratinocytes were seeded onto 9.6-cm2 wells
(60,000 cells per well) and transfected when 80% confluent.
Transfection was performed for 6 hours in medium containing
Lipofectamine 2000 (Invitrogen Life Technologies, Carlsbad, CA)
and DNA (in the range of 2.5–10.5mg). A 0.5-mg weight of
pCMV-lacZ was used as the control for transfection efficiency. A
4-ml volume of Lipofectamine per 1mg of total DNA was used.
Transfection assays were performed in triplicate. Transfection
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medium was then removed and keratinocytes were allowed to
recover in fresh medium for 48 hours. Culture was harvested with
lysis buffer (Promega, Wisconsin, MA). Luciferase activity was
determined and normalized to b-galactosidase activity.
Cell culture treatments
All the treatments were performed on human primary keratinocytes
at the third–fourth cell culture passage.
Sixty thousand keratinocytes were plated and subcultured for 4
days. Treatment with increasing doses of H2O2 (from 125 to 6mM)
was performed in three different media, namely complete medium
(EGFþ ); complete medium without EGF (EGF); a medium without
EGF, other hormones/growth factors, and fetal bovine serum
(starvation medium). After 24 hours, the medium was removed and
fresh medium was added to cultures, which were then collected at
different recovery times (0–6 days) for further analyses. To evaluate
cell proliferation, the number of cells of untreated and treated
cultures was counted at each time of recovery. Cell extracts prepared
from these keratinocyte cultures were subjected to western blot
analysis (see above). CFE of control and treated keratinocytes was
determined at selected times of recovery (CFE of control cells at
2 days and from H2O2-treated cells at 2 and 6 days after treatment)
following the aforementioned protocol.
To mimic the condition of growth factor/stromal cell deprivation,
keratinocytes were cultivated in serum-free medium (KBM from
Cambrex, East Rutherford, NJ) without the 3T3-J2 feeder layer.
Keratinocyte cultures were treated with different doses (50 to
150 nM) of TSA (Sigma-Aldrich, St Louis, MO) for 4 days and
immediately processed.
Statistical analysis
Statistical analysis was performed using Student’s t-test. P-values less
than 0.05 were considered significant.
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